All Stories

  1. Retrospective analysis of drug utilization, health care resource use, and costs associated with IFN therapy for adjuvant treatment of malignant melanoma

    Article • ClinicoEconomics and Outcomes Research, July 2015, Dove Medical Press

    Ms Ying Zhang